Constipation Chronic Idiopathic
15
3
4
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (15)
Maralixibat in Patients With Cystic Fibrosis and Constipation
MOWOOT Device Treatment for Adults With Chronic Constipation
Soluble and Osmotic Fibre (SOLOS) Diet for Constipation
MowOot and Trans-anal Irrigation fOr coNstipation
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
A Pilot Study to Explore the Role of Gut Flora in Chronic Constipation
Efficacy of a Dietary Intervention for the Treatment of Constipation in Institutionalized Older Adults. Medellín, 2023-2024.
Vibrant Capsule vs. Placebo for Patient Suffering From Constipation
Effect of Abdominal Massage Versus Visceral Manipulation on Constipation
Comparison of Efficacy & Tolerability Of PEG 4000 Versus PEG 3350+ Electrolytes for Pediatric Fecal Disimpaction
Do the Symptoms of Chronic Constipation Improve With a Primary Care Programme Based on Behavioural Re-education and Abdominal Massage?
Evaluation of the Triple Management Program in the Management of Functional Chronic Constipation in Children
Tolerability Study of Panosyl Isomaltooligosaccharides (PIMO), in Subjects With Chronic Idiopathic Constipation (CIC)
MOWOOT Device to Treat Constipation in Adults